EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

A comparison of porcine anti-human T lymphocyte immunoglobulin, rabbit-ATG for GVHD prophylaxis and without ATG in matched sibling donor transplantation

Shiyuan Zhou, Chao Ma, Danping Zhou, Qian Zhu, Wenjuan Zhu, Jing Li, Depei Wu, Xiao Ma, Xiaojin Wu

Current Research in Translational Medicine · 2025

DOI: 10.1016/j.retram.2025.103501 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Current Research in Translational Medicine, 2025. Verfasst von Shiyuan Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Soochow University, Suzhou, PR China; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute …. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Antilymphocyte Serum, Hematologic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Priority Academic Program Development of Jiangsu Higher Education Institutions, National Key Research and Development Program of China, National Major Science and Technology Projects of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Research on anti-lymphocyte globulins other than rabbit anti-thymocyte globulin (r-ATG) in prevention of graft-versus-host-disease (GVHD) following HLA-matched siblings hematopoietic stem cell transplantation (MSD-HSCT) is limited. The objective of this study is to investigate the distinct impacts of porcine anti-human T lymphocyte immunoglobulin (p-ATG) and r-ATG on outcomes of MSD-HSCT in patients with hematologic malignancies. PATIENTS AND METHODS: This retrospective analysis enrolled 373 consecutive patients who underwent MSD-HSCT from January 2019 to October 2023. 135 patients received r-ATG (5mg/kg) and 51 received p-ATG (30mg/kg) for GVHD prophylaxis. 187 did not receive r-ATG or p-ATG. RESULTS: Despite early deaths, no engraftment failure occurred. In the r-ATG group, neutrophil engraftment was observed earlier, while platelet engraftment was delayed compared to other groups. Both r-ATG and p-ATG group showed protective effect on chronic graft-versus-host disease (cGVHD) (13.9 % and 29.6 % respectively vs. 43.0 % of control group at 2 years post HSCT), whereas only the r-ATG group displayed a decreased acute GVHD (aGVHD) rate (24.9 % vs. 39.8 % of control group at day 100 post HSCT). GVHD-free and relapse-free survival (GRFS) were found superior in both r-ATG and p-ATG groups (63.4 % and 56.8 % respectively vs. 37.0 % of control group at 2 years post HSCT). R-ATG was identified as an independent protective factor for aGVHD, cGVHD and GRFS in multivariate analysis. CONCLUSIONS: Our study further confirmed the role of ATG in MSD-HSCT for improving the outcomes. No evidence supported substituting r-ATG with p-ATG in achieving these effects in the study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationAntilymphocyte SerumHematologic NeoplasmsHumansMaleRetrospective StudiesFemaleSiblingsAnimalsSwineAdultMiddle AgedAdolescentRabbitsYoung AdultChildT-LymphocytesTreatment Outcome

Stichwörter der Autor:innen

Graft-versus-host diseasePorcine anti-human T lymphocyte immunoglobulinRabbit anti-thymocyte globulinStem cell transplantation

Substanzen

Antilymphocyte Serum

Autor:innen und Institutionen

  • The First Affiliated Hospital of Soochow University, Suzhou, PR China; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, PR China; Institute of Blood and Marrow Transpl…
  • Hematology Department, Soochow Hopes Hematonosis Hospital, Suzhou, PR China.

Förderung

  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • National Key Research and Development Program of China
  • National Major Science and Technology Projects of China
  • Key Technologies Research and Development Program
  • National Natural Science Foundation of China

Zitieren

APA

Zhou, S., Ma, C., Zhou, D., Zhu, Q., Zhu, W., Li, J., Wu, D., Ma, X., & Wu, X. (2025). A comparison of porcine anti-human T lymphocyte immunoglobulin, rabbit-ATG for GVHD prophylaxis and without ATG in matched sibling donor transplantation. Current Research in Translational Medicine. https://doi.org/10.1016/j.retram.2025.103501

Vancouver

Zhou S, Ma C, Zhou D, Zhu Q, Zhu W, Li J, et al. A comparison of porcine anti-human T lymphocyte immunoglobulin, rabbit-ATG for GVHD prophylaxis and without ATG in matched sibling donor transplantation. Current Research in Translational Medicine. 2025. doi:10.1016/j.retram.2025.103501

BibTeX
@article{Zhou2025,
  author = {Zhou, Shiyuan and Ma, Chao and Zhou, Danping and Zhu, Qian and Zhu, Wenjuan and Li, Jing and Wu, Depei and Ma, Xiao and Wu, Xiaojin},
  title = {A comparison of porcine anti-human T lymphocyte immunoglobulin, rabbit-ATG for GVHD prophylaxis and without ATG in matched sibling donor transplantation},
  journal = {Current Research in Translational Medicine},
  year = {2025},
  doi = {10.1016/j.retram.2025.103501}
}
Kostenlos starten →